Model Number 8637-20 |
Device Problems
Occlusion Within Device (1423); Premature End-of-Life Indicator (1480); Premature Elective Replacement Indicator (1483); Device Displays Incorrect Message (2591); Inappropriate or Unexpected Reset (2959)
|
Patient Problems
Headache (1880); Nausea (1970); Pain (1994); Dizziness (2194); Therapeutic Response, Decreased (2271); Complaint, Ill-Defined (2331); Malaise (2359)
|
Event Date 03/22/2017 |
Event Type
Injury
|
Manufacturer Narrative
|
A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Information was received from a healthcare provider on (b)(6) 2017 regarding a patient's implanted infusion pump containing bupivacaine (0.1mg/ml at 0.4495mg/day) and morphine (20mg/ml at 8.99mg/day).The indications for use included non-malignant pain and lumbar radiculopathy.It was reported that the patient's pump was alarming, and via telemetry, it was found that the elective replacement indicator (eri) occurred on (b)(6) 2017, followed by multiple resets and low battery resets on (b)(6) 2017, and finally end of service (eos) on (b)(6) 2017.The patient was not doing very well and was getting worse, with flu-like symptoms, wooziness, headache, nausea, and increased pain.The symptoms started gradually on the morning of (b)(6) 2017, and slowly got worse.Surgery was scheduled for (b)(6) 2017 at 15:00 to replace the pump.
|
|
Event Description
|
Additional information received reported that during the pump replacement procedure it was noted that they elected to change the catheter connector.No further complications were reported/anticipated.
|
|
Manufacturer Narrative
|
A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
No further complications were reported or expected.
|
|
Manufacturer Narrative
|
Concomitant products: product id: 8731, serial# (b)(4), implanted: (b)(6) 2004, product type: catheter.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Additional information received reported that the pump had premature eos (end of service).The company representative was in the revision case and stated that the catheter was not patent so they were revising the catheter.They ended up replacing the connector and 23 cm of catheter.It was additionally noted that on (b)(6) 2017 the patient heard the alarm.On (b)(6) 2017 the home care agency interrogated the patient¿s pump and premature eri (elective replacement indicator) alarm had been occurring.The reporter stated it was premature because on (b)(6) 2017 it showed 12 months until eri (elective replacement indicator).On (b)(6) 2017 eos (end of service) alarm, critical alarm occurred.The patient started experiencing early stages of withdrawal.On (b)(6) 2017 the pump was successfully replaced.No further complications were reported/anticipated.
|
|
Event Description
|
Additional information was received and it was reported that the cause for the low battery resets, eri (elective replacement indicator), and eos (end of service) was unknown.The pump was explanted and the patient¿s symptoms resolved.No further complications were reported/anticipated.
|
|
Manufacturer Narrative
|
The pump had been programmed to deliver 1.0 mg/ml of bupivacaine at 0.4455 mg/day, rather than 0.1 mg/ml of bupivacaine at 0.4455 mg/day, as initially reported.Analysis results were not available at the time of this report.A follow-up report will be sent when analysis is completed.(b)(4).
|
|
Event Description
|
The device was returned to the manufacturer on april 05, 2017.
|
|
Manufacturer Narrative
|
Analysis of the pump found low battery reset of an undetermined root cause.Conclusion code ¿ is being updated for this event.Result code no longer applies.Recent fda coding changes offer limited options for medical device evaluation conclusion coding.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Manufacturer Narrative
|
If information is provided in the future, a supplemental report will be issued.
|
|
Manufacturer Narrative
|
If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|